The World Health Organization (WHO) today approved the Indian vaccine against COVID-19 Covovax, the agency said in a statement.
This vaccine “is produced by the Serum Institute of India under license from Novavax and is part of the portfolio of Covax (Covid International Vaccine Distribution System), which will enhance efforts to vaccinate more people in low income “, underlined the WHO.
“Vaccines remain one of the most effective methods of protection against severe forms and deaths caused by SARS-COV-2, despite the emergence of new variants,” said Dr. Mariangela Simaou, WHO for access to medicines.
“This approval is expected to facilitate access to vaccines for poor countries, 41 of which are still unable to vaccinate 10% of their population, while 98% of countries have not yet reached 40%,” he said. as the WHO has targeted the vaccination of 40% of the population of all countries by the end of the year.
This vaccine requires two doses and can be stored at temperatures of 2 to 8 degrees, as in commercial refrigerators.
Source: AMPE
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
